Oyster Point Pharma Unveils Operating Expense Reduction Plan; Plans job cuts

0






Newswires MT 2022

All news about OYSTER POINT PHARMA, INC.

2022 sales 33.0 million

2022 net income -168M

Net cash 2022 49.0M

PER 2022 ratio -0.76x
2022 return
Capitalization 125 million
125 million
EV / Sales 2022 2.29x
EV / Sales 2023 1.28x
# of employees 303
Floating 94.6%

Chart OYSTER POINT PHARMA, INC.


Duration :

Period :




Oyster Point Pharma, Inc. Technical Analysis Chart |  MarketScreener

Trends in Technical Analysis OYSTER POINT PHARMA, INC.

Short term Middle term Long term
Tendencies Bullish Bearish Bearish



Evolution of the income statement

Sale

To buy

Medium consensus TO BUY
Number of analysts 4
Last closing price $4.67
Average target price $32.75
Average Spread / Target 601%


Share.

Comments are closed.